Fleming Pharmaceuticals leverages internal agility and areas of expertise to bring value to partners and stakeholders. We have cultivated long-term partnerships and maximized shared strengths to be able to quickly bring advances to patients and physicians.
Our development strategy focuses on growing market segments in strategically selected disease states with unmet clinical needs. Timely decision making and allocation of appropriate resources make Fleming an ideal partner for collaborations on product development and commercialization.
We are seeking new products for co-promotion, acquisition, or in-license in the current areas of interest. Many companies have products needing commercial sales and marketing support. Other companies are considering divesting or out-licensing non-strategic products. In either case, Fleming’s sales and marketing team can help.
To find out more about collaborative opportunities and areas of interest, please contact me.